Thus, ROBO1 and ROBO2 may be considered to be tumour-suppressor genes in cancers, a notion that is also supported by our SNV and SNP data in lower and higher risk cases with MDS. This evidence concerns the gene ROBO1 and myelodysplastic syndrome.